Veloxis Pharmaceuticals, Inc

A Formula for the Future of Transplant Patient Therapy

Veloxis is focused on the direct commercialization of immunosuppression medications in the US, expansion of partnerships for markets around the world, and acquisition of assets utilized in transplant patients and by adjacent medical specialties.

Podcast Episodes

Subscribe to Kidney Transplant Conversations

Kidney Transplant Conversations is a podcast focused on quality healthcare delivery and the innovative approaches kidney transplant recipients and providers are applying to improve care. The series also addresses health disparities in renal transplant and what can be done to close the gaps. These discussions include important explorations of inclusion, diversity, equity, and access.

We invite you to listen and let Kidney Transplant Conversations keep you connected, informed, and inspired with a constant flow of new thoughts and ideas.

Kidney Transplant Conversations is underwritten by Veloxis Pharmaceuticals, Inc.

All views and opinions expressed in this podcast reflect those of the participants and do not necessarily represent the views and opinions of Veloxis Pharmaceuticals, Inc.

Optimizing Long-term Care for Renal Transplant Recipients

The aim of this program is to engage renal care specialists in a dynamic case-based discussion of long-term care in kidney transplantation. A leading expert will explore evolving treatment paradigms, which may help inform care optimization, including strategies for long-term immunosuppressive therapy.
View Webinar (33 min)
Learn more at veloxis.com
Copyright © 2021 Veloxis Pharmaceuticals, Inc. All rights reserved. US-UNB-2100011 v1.0 9/21

Please provide some basic information to access this content.